HMGB1 and kidney disorder: Multiple studies have shown that serum HMGB1 is predictive of the outcomes of end-stage liver and renal disease (Leelahavanichkul et al., 2011; Zhang et al., 2014; Dai et al., 2021; Dos Santos Pinheiro et al., 2022).